Latest Breaking News On - தனிப்பட்ட சிகிச்சை - Page 4 : comparemela.com

Sök 2cureX announces that the clinical trial of IndiTreat®-guided treatment of metastatic colorectal cancer has met the primary endpoint. 2cureX announced today that its prospective interventional clinical trial investigating the benefit of IndiTreat®-guided treatment achieved its primary endpoint by improving Progression Free Survival (PFS) after eight weeks of treatment. Full data has been submitted to the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting. 2cureX Publicerad: 1 mars 2021, 13:00 “These results show there’s a significant improvement for patients when treated according to the IndiTreat® test” said Ole Thastrup, 2cureX’s Chief Scientific Officer. “This is an important achievement in this historically hard-to-treat disease. We are deeply appreciative of the cancer patients and clinical investigators who participated in this trial”.

Fernando andreuOle thastrupChief scientificCo sponsored meetingsIndividual treatmentNasdaq first north growth marketபெர்னாண்டோ அன்றெனுதலைமை அறிவியல்இணை ஆதரவளிக்கப்பட்ட கூட்டங்கள்தனிப்பட்ட சிகிச்சைநாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை